Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,129.51
(
-0.13%
)
US TECH 100
26,383.20
(
0.31%
)
Dow Jones
48,810.32
(
-0.67%
)
Brent Oil
110.97
(
6.28%
)
Bitcoin
75,842.79
(
-0.66%
)
News Focus
News Focus
Post# of 108195
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122904
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ignatiusrielly35 post# 27315

Monday, 07/24/2017 1:26:38 PM

Monday, July 24, 2017 1:26:38 PM

Post# of 108195
Data will be released after the AIM2CERV interim analysis only if the trial is halted early because of overwhelming efficacy relative to the expectations of the trial designers.

In the more likely case where the trial continues to the final analysis as planned, the decision to continue the trial will be the only info provided to investors (or to the company itself).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up